Cutting Edge Treatments: Here's What Coming Next

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

Cutting Edge Treatments: Here's What Coming Next

Listen for free

View show details

The pace of change in metastatic breast cancer treatment is accelerating at an unprecedented rate. In this episode, we examine the groundbreaking therapies emerging from recent clinical trials and explore what this rapid evolution means for patients living with HR-positive, HER2-negative metastatic disease. We discuss how precision medicine is reshaping treatment strategies, the promise of combination therapies, and why the next five years could fundamentally transform how we approach this complex disease. About Dr. Eleonora Teplinsky Dr. Teplinsky is Head of Breast and Gynecologic Medical Oncology at Valley Mount Sinai Comprehensive Cancer Care and Clinical Assistant Professor of Medicine at Mount Sinai. She specializes in metastatic breast cancer treatment and is a recognized expert in precision oncology approaches for advanced disease. In this episode, we explore: (03:07) Progress in hormone receptor-positive metastatic disease (05:57) Late-stage trials ending soon (07:36) The groundbreaking SERENA-6 trial and preemptive treatment switching (11:25) Balancing hope with realistic expectations (13:12) Accessing cutting-edge treatments outside major cancer centers (16:34) When and how to pursue clinical trials throughout your journey (18:22) Understanding what makes a new treatment right for you (22:47) The treatment landscape five years from now (23:59) What's coming next Learn more about your ad choices. Visit podcastchoices.com/adchoices

No reviews yet